The objective of the current study was to determine if circulating adipokines other than adiponectin also associate with the future development of RA and if the association between circulating levels of adiponectin and higher risk of RA is independent of other adipokines. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.